Shunting of portal-hypertensive-associated insulin from the portal venous system into the systemic circulation causes hyperinsulinemia, insulin receptor desensitization and insulin downregulation, leading to insulin resistance (30). This evidence concerns the gene INS and hyperinsulinism.